Stockscreener 앱 받기
1.93
0.52%
-0.01
시간 외 거래:
1.91
-0.02
-1.04%
전일 마감가:
$1.94
열려 있는:
$1.93
하루 거래량:
55,713
Relative Volume:
0.49
시가총액:
$280.73M
수익:
-
순이익/손실:
-
주가수익비율:
-8.5892
EPS:
-0.2247
순현금흐름:
-
1주 성능:
-3.98%
1개월 성능:
-9.39%
6개월 성능:
-3.50%
1년 성능:
-19.92%
1일 변동 폭
$1.91
$1.95
1주일 범위
$1.90
$2.05
52주 변동 폭
$1.66
$3.335
Immutep Limited Adr Stock (IMMP) Company Profile
IMMP을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
IMMP
Immutep Limited Adr
|
1.93 | 280.73M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
422.00 | 108.68B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
681.58 | 74.90B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
640.52 | 38.30B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
246.27 | 31.76B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
111.93 | 26.83B | 3.30B | -501.07M | 1.03B | -2.1146 |
Immutep Limited Adr Stock (IMMP) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-05-17 | 개시 | CapitalOne | Overweight |
| 2023-08-03 | 개시 | Robert W. Baird | Outperform |
| 2021-08-03 | 개시 | Ladenburg Thalmann | Buy |
| 2021-07-16 | 재개 | Maxim Group | Buy |
| 2018-09-28 | 개시 | B. Riley FBR | Buy |
| 2018-02-15 | 재확인 | Maxim Group | Buy |
모두보기
Immutep Limited Adr 주식(IMMP)의 최신 뉴스
Immutep Limited (NASDAQ:IMMP) Shares Sold by Jane Street Group LLC - Defense World
Verition Fund Management LLC Has $57,000 Stock Position in Immutep Limited (NASDAQ:IMMP) - Defense World
Immutep Announces Initial Safety Data from First-in-Human Phase I Trial Evaluating IMP761 - The Manila Times
Immutep Announces Initial Safety Data from First-in-Human Phase I Trial Evaluating IMP761 - GlobeNewswire Inc.
Immutep shares new cancer study results - Investing.com
Immutep Quarterly Activities Report Q1 FY25 - GlobeNewswire
Immutep Announces First-in-Human Phase I Study of IMP761 Progresses to Dose Escalation Portion of Trial - The Manila Times
Immutep Limited ADR (IMMP) Stock: Navigating a Year of Stock Volatility - The InvestChronicle
Metric Deep Dive: Understanding Immutep Limited ADR (IMMP) Through its Ratios - The Dwinnex
Immutep reports positive results in cancer study - Investing.com
Dow Jumps Over 200 Points; NY Empire State Manufacturing Index Increases In September - Benzinga
Research Analysts Issue Forecasts for Immutep Limited’s FY2025 Earnings (NASDAQ:IMMP) - Defense World
Immutep Limited ADR (IMMP) Stock: Navigating a Year of Volatility - The InvestChronicle
Short Interest in Immutep Limited (NASDAQ:IMMP) Declines By 10.1% - Defense World
Immutep Announces First Participant Dosed in Phase I Study of IMP761, a First in Class Agonist LAG-3 Antibody - GlobeNewswire
Virtu Financial LLC Buys 32,864 Shares of Immutep Limited (NASDAQ:IMMP) - Defense World
Immutep reports steady progress in Q4 FY24 - Investing.com India
Immutep reports steady progress in Q4 FY24 By Investing.com - Investing.com Australia
Immutep Limited (NASDAQ:IMMP) Shares Acquired by BNP Paribas Financial Markets - Defense World
Immutep Announces Successful Meeting with FDA on Phase III Design in Non-Small Cell Lung Cancer - GlobeNewswire
Guess which ASX healthcare stock is surging on big FDA news - The Motley Fool
Why 29Metals, Immutep, Insignia, and Perenti shares are pushing higher today - The Motley Fool
FY2027 EPS Estimates for Immutep Limited (NASDAQ:IMMP) Cut by Capital One Financial - American Banking and Market News
Equities Analysts Set Expectations for Immutep Limited’s FY2029 Earnings (NASDAQ:IMMP) - American Banking and Market News
Immutep Limited (NASDAQ:IMMP) Short Interest Up 6.2% in June - American Banking and Market News
Immutep Receives Regulatory Clearance for Phase I Study of - GlobeNewswire
Baird cuts Immutep stock target on phase 2b trial results, retains Outperform - Investing.com
Stocks of the Hour: Adherium, Nanoveu, Nimy Resources - ShareCafe
Immutep appoints research institute to conduct first-in-human study of IMP761 - Biotech Dispatch
10 Best Australian Stocks To Buy - Yahoo Finance
Immutep LimitedADR (IMMP) Price Target Increased by 7.83% to 2.80 - MSN
Immutep Announces GMP Manufacturing Process Developed for - GlobeNewswire
Check Up: These 4 ASX healthcare stocks come with Strong Buy recommendations - Stockhead
The Daily Biotech Pulse: Moderna To Kickstart Phase 3 Study On July 27, Immutep Awarded Antibody Patent - Yahoo Finance
Immutep Ltd (IMMP) Stock Price, Trades & News - GuruFocus.com
Benzinga's Daily Biotech Pulse: Organovo Falls On Earnings; Celgene Gets New CFO - Yahoo Finance
Immutep Limited Adr (IMMP) 재무 분석
Immutep Limited Adr (IMMP)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
0.65%
4.62%
자본화:
|
볼륨(24시간):